Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 536-541

  Gamallat, Yaser ^a   Meyiah, Abdo ^a   Kuugbee, Eugene D ^a   Hago, Ahmed Musa ^a   Chiwala, Gift ^a   Awadasseid, Annoor ^a   Bamba, Djibril ^a   Zhang, Xin ^a   Shang, Xueqi ^a   Luo, Fuwen ^a   Xin, Yi ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Colon cancer; Inflammation; Lactobacillus

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BETA CATENIN; CASPASE 3; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROBIOTIC AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; COLON CANCER; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG POTENCY; EPITHELIUM CELL; FEMALE; FOLLOW UP; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; CARCINOGENESIS; COLON TUMOR; DISEASE COURSE; DISEASE MODEL; INFLAMMATION; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CARCINOGENESIS; COLONIC NEOPLASMS; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; INFLAMMATION; LACTOBACILLUS RHAMNOSUS; NEOVASCULARIZATION, PATHOLOGIC; PROBIOTICS; RATS, SPRAGUE-DAWLEY; TUMOR BURDEN;

EID: 84978715613     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.07.001     Document Type: Article

References (44)

1. [1] Siegel, R., DeSantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA: Cancer J. Clin. 64:2 (2014), 104–117.
2. [2] Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., He, J., Cancer statistics in China, 2015. CA: Cancer J. Clin. 66:2 (2016), 115–132.
3. [3] Gill, H.S., Rutherfurd, K.J., Prasad, J., Gopal, P.K., Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83:2 (2000), 167–176.
4. [4] Schiffrin, E.J., Rochat, F., Link-Amster, H., Aeschlimann, J.M., Donnet-Hughes, A., Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78:3 (1995), 491–497.
5. [5] Nicolini, A., Ferrari, P., Masoni, M.C., Fini, M., Pagani, S., Giampietro, O., Carpi, A., Malnutrition, anorexia and cachexia in cancer patients: a mini-review on pathogenesis and treatment. Biomed. Pharmacother. 67:8 (2013), 807–817.
6. [6] Guandalini, S., Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol., 45(53), 2011.
7. [7] Rosenfeldt, V., Benfeldt, E., Nielsen, S.D., Michaelsen, K.F., Jeppesen, D.L., Valerius, N.H., Paerregaard, A., Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111:2 (2003), 389–395.
8. [8] Lee, D.K., Jang, S., Baek, E.H., Kim, M.J., Lee, K.S., Shin, H.S., Chung, M.J., Kim, J.E., Lee, K.O., Ha, N.J., Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis. 8:1 (2009), 1–8.
9. [9] Lee, S.K., Yang, K.M., Cheon, J.H., Kim, T.I., Kim, W.H., Anti-inflammatory mechanism of Lactobacillus rhamnosus GG in lipopolysaccharide- stimulated HT-29 cell. Korean J. Gastroenterol. 60:2 (2012), 86–93.
10. [10] van Wijk, F., Knippels, L., Initiating mechanisms of food allergy: oral tolerance versus allergic sensitization. Biomed. Pharmacother. 61:1 (2007), 8–20.
11. [11] Evrard, B., Coudeyras, S., Dosgilbert, A., Charbonnel, N., Alamé, J., Tridon, A., Forestier, C., Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One, 6(4), 2011, e18735.
12. [12] Aggarwal, B.B., Gehlot, P., Inflammation and cancer: how friendly is the relationship for cancer patients?. Curr. Opin. Pharmacol. 9:4 (2009), 351–369.
13. [13] Setia, S., Nehru, B., Sanyal, S.N., Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis. Biomed. Pharmacoth. 68:1 (2014), 119–128.
14. [14] Wang, L., Zhang, Q., Application of the ApcMin/+ mouse model for studying inflammation-associated intestinal tumor. Biomed. Pharmacother. 71 (2015), 216–221.
15. [15] Li, H., Guo, Q., Zhou, B., He, S., Cyclooxygenase-2 gene polymorphisms and the risk of colorectal cancer: a population-based study. Oncol. Lett. 10:3 (2015), 1863–1869.
16. [16] Brenner, D.R., Scherer, D., Muir, K., Schildkraut, J., Boffetta, P., Spitz, M.R., LeMarchand, L., Chan, A.T., Goode, E.L., Ulrich, C.M., Hung, R.J., A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol. Biomarkers Prev. 23:9 (2014), 1729–1751.
17. [17] Shanmugam, C., Katkoori, V.R., Jhala, N.C., Grizzle, W.E., Siegal, G.P., Manne, U., p53 nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior. J. Histochem. Cytochem. 56:March (3) (2008), 305–312.
18. [18] Zhu, Q., Jin, Z., Wu, W., Gao, R., Guo, B., Gao, Z., Yang, Y., Qin, H., Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One, 9(3), 2014, e90849.
19. [19] Corpet, D.E., Pierre, F., How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur. J. Cancer 41:13 (2005), 1911–1922.
20. [20] Le Leu, R.K., Hu, Y., Brown, I.L., Woodman, R.J., Young, G.P., Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31:2 (2010), 246–251.
21. [21] Weng, H., Deng, Y., Xie, Y., Liu, H., Gong, F., Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors. BMC Cancer, 13, 2013, 311.
22. [22] Vaiopoulos, A.G., Athanasoula, K.C., Papavassiliou, A.G., NF-κB in colorectal cancer. J. Mol. Med. 91:9 (2013), 1029–1037.
23. [23] Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., Ben-Neriah, Y., NF-[kappa]B functions as a tumour promoter in inflammation-associated cancer. Nature 431:7007 (2004), 461–466.
24. [24] Wang, S., Liu, Z., Wang, L., Zhang, X., NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell. Mol. Immunol. 6:5 (2009), 327–334.
25. [25] Femia, A.P., Luceri, C., Toti, S., Giannini, A., Dolara, P., Caderni, G., Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. BMC Cancer, 10, 2010, 194.
26. [26] Huang, S., DeGuzman, A., Bucana, C.D., Fidler, I.J., Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6 (2000), 2573–2581.
27. [27] Iyer, C., Kosters, A., Sethi, G., Kunnumakkara, A.B., Aggarwal, B.B., Versalovic, J., Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell. Microbiol. 10 (2008), 1442–1452.
28. [28] Wang, H.F., Tseng, C.Y., Chang, M.H., Lin, J.A., Tsai, F.J., Tsai, C.H., Lu, Y.C., Lai, C.H., Huang, C.Y., Tsai, C.C., Anti-inflammatory effects of probiotic Lactobacillus paracasi on ventricles of BALB/C mice treated with ovalbumin. Chin. J. Physiol. 55:1 (2012), 37–46.
29. [29] Sharma-Walia, N., Paul, A.G., Bottero, V., Sadagopan, S., Veettil, M.V., Kerur, N., Chandran, B., Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog., 6(2), 2010, e1000777.
30. [30] Arber, N., Proceedings of the 1st Annual Conference of OOTR COX-2 and Angiogenesis in OncologyChemoprevention of colorectal cancer; the role of COX 2 inhibitors, from the bench to the bed-side. Biomed. Pharmacother., 59, 2005, S332.
31. [31] Sappayatosok, K., Maneerat, Y., Swasdison, S., Viriyavejakul, P., Dhanuthai, K., Zwang, J., Chaisri, U., Expression of pro-inflammatory protein, iNOS VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med. Oral Patol. Oral Cir. Bucal 14:7 (2009), E319–24.
32. [32] Huang, S., DeGuzman, A., Bucana, C.D., Fidler, I.J., Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6:6 (2000), 2573–2581.
33. [33] Khailova, L., Petrie, B., Baird, C.H., Dominguez Rieg, J.A., Wischmeyer, P.E., Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis. PLoS One, 9(5), 2014.
34. [34] Elmore, S., Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35:4 (2007), 495–516.
35. [35] Sakatani, A., Fujiya, M., Ueno, N., Kashima, S., Sasajima, J., Moriichi, K., Ikuta, K., Tanabe, H., Kohgo, Y., Polyphosphate derived from lactobacillus brevis inhibits colon cancer progression through induction of cell apoptosis. Anticancer Res. 36:2 (2016), 591–598.
36. [36] Tong, Y., You, L., Liu, H., Li, L., Meng, H., Qian, Q., Qian, W., Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia. Oncotarget 4:6 (2013), 860–874.
37. [37] Otte, J.M., Mahjurian-Namari, R., Brand, S., Werner, I., Schmidt, W.E., Schmitz, F., Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr. Cancer 61:1 (2009), 103–113.
38. [38] Walia, S., Kamal, R., Kanwar, S.S., Dhawan, D.K., Cyclooxygenase as a target in chemoprevention by probiotics during 1 2-dimethylhydrazine induced colon carcinogenesis in rats. Nutr. Cancer 67:4 (2015), 603–611.
39. [39] Caffrey, A.S., Patton, W.C., Corselli, J.U., Swensen, R.E., King, A., Chan, P.J., Cyclooxygenase (COX)-2 and granulosa cell apoptosis In vitro. J. Assist. Reprod. Genet. 19:12 (2002), 577–581.
40. [40] Han, J.A., Kim, J.-I., Ongusaha, P.P., Hwang, D.H., Ballou, L.R., Mahale, A., Aaronson, S.A., Lee, S.W., p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J. 21:21 (2002), 5635–5644.
41. [41] Wu, S., Yuan, L., Zhang, Y., Liu, F., Li, G., Wen, K., Kocher, J., Yang, X., Sun, J., Probiotic Lactobacillus rhamnosus GG mono-association suppresses human rotavirus-induced autophagy in the gnotobiotic piglet intestine. Gut Pathog., 5, 2013, 22.
42. [42] Lin, W.-W., Karin, M., A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117:5 (2007), 1175–1183.
43. [43] Jung, Y.-S., Jun, S., Lee, S.H., Sharma, A., Park, J.-I., Wnt2 complements Wnt/β-catenin signaling in colorectal cancer. Oncotarget 6:35 (2015), 37257–37268.
44. [44] Sadot, E., Geiger, B., Oren, M., Ben-Ze'ev, A., Down-regulation of β-catenin by activated p53. Mol. Cell. Biol. 21:20 (2001), 6768–6781.